Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

L A Henry(Breast Cancer Now), Damian A. Johnson(Breast Cancer Now), David Sarrió(Institute of Cancer Research), S Lee(Breast Cancer Now), Philip Quinlan(University of Dundee), T Crook(Institute of Cancer Research), Alastair M. Thompson(Ninewells Hospital), Jorge S. Reis‐Filho(Breast Cancer Now), Clare M. Isacke(Institute of Cancer Research)

Oncogene

November 1, 2010

10.1038/onc.2010.488

Cited by 62

Abstract

Related Papers

Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

Kimberly A. McAllister, K.M. Grogg, David W. Johnson et al.|Nature Genetics|1994|1.5k

Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2

David W. Johnson, Jonathan Berg, Melanie A. Baldwin et al.|Nature Genetics|1996|1.1k

Modelling glandular epithelial cancers in three-dimensional cultures

Jayanta Debnath, Joan S. Brugge|Nature reviews. Cancer|2005|998

Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity

Barish Ozdamar, Rohit Bose, Miriam Barrios‐Rodiles et al.|Science|2005|866

Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.

Sela Cheifetz, Teresa Bellón, Carmela Calés et al.|Journal of Biological Chemistry|1992|836